Searched for
CADILA PHARMA CMD
Indian Pharma not too worried over Trump talkIndian pharma companies say American firms can't match low prices.
Make In India: Pharma entrepreneurs urge industry to address compliance issuesShanghvi said companies need to move beyond being mere generic players and look to innovate to capture the potential $800-billion pharmaceu...
Kumar Mangalam Birla, other India Inc bosses may head IIT boardsApart from Birla, the ministry is also understood to have zeroed in on some other leading figures from the industry to head these prestigio...
US big market for Indian pharma cos despite FDA run-ins: Pankaj Patel, Zydus CadilaPatel says the US offers Indian drug firms bigger opportunities despite the latest run-ins with the FDA.
Cadila Pharmaceuticals ties up with NovaSAID for drug developmentNovaSAID AB and Ahmedabad-based drug maker Cadila have entered into a strategic partnership to develop new treatments for inflammation and ...
Cadila Pharma Chairman Indravadan Modi dies at 87Founder of Ahmedabad-based Cadila Pharmaceuticals, Indravadan Modi, better known as the octogenarian horse-riding chairman, passed away at ...
- Zydus Cadila acquires 100% stake Mumbai based Biochem
Biochem has a presence in various therapeutic segments, including antibiotics, cardiovascular, anti-diabetics and oncology.
- Zydus applies for Phase II & III H1N1 vaccine trials
The race amongst Indian swine flu vaccine-makers seems to be moving to the next level with Cadila Healthcare Ltd, the Rs 2,900-crore Zydus ...
- Zydus Cadila gets DCGI nod to conduct trials for H1N1 vaccine
Drug maker Zydus Cadila on Monday said it has received approval from the Drug Controller General of India (DCGI) for conducting clinical tr...
- Govt to spend $2 b annually till ’20 on drug discovery
The Department of Pharmaceuticals (DoP) will soon come out with a White Paper on Vision 2020.
- Zydus Cadila buys Dutch firm Etna Biotech
The Ahmedabad-based pharma major Zydus Cadila on Tuesday said it has acquired Etna Biotech, a subsidiary of the Dutch biopharma company, Cr...
- Pay more for new asthma drugs
In an attempt to thwart price control, drug majors have withdrawn or reduced supplies of popular asthma drug Theophylline.
- Zydus bets on off-patent generics
The company plans to launch 100 drugs in US & Europe over the next five years.
- Pharma cos set sights on Japan
As pricing pressure intensifies in the US generics market, Indian pharma majors are planning rapid inroads into Japan, which is the worlds ...
- Zydus Cadila closes in on Spanish deal for $30 mn
Continuing with its strategy of inorganic route to drive its global growth, Ahmedabad-based Zydus Cadila is close to acquiring a mid-size p...
- Zydus scouts for partners in Land of Rising Sun
The company is in talks with 2-3 pharma companies and has earmarked an investment of about $25 million for its expansion plans in Japan.
- Indian pharma cos close to blockbuster breakthrough
Indian pharma majors may manage to market their first indi-genous "blockbuster drugs" or new chemical entities (NCEs) in the next four year...